Credit Suisse lowers its rating on Synovus Financial SNV to Neutral from Outperform as it embeds DTA recovery and M&A potential into model.
Credit Suisse notes, "With the stock at a modest premium to peers on pre-rate hike '14
EPS and 1.0x current TBV (TBV will rise w/ DTA recovery), we now estimate our thesis of DTA recovery (in next 12 months) and successful TARP repayment by YE '13 is now expected by the market. Additionally, at these levels, we estimate the M&A opportunity is weaker given lower accretion potential for acquirers."
SNV closed at $2.14 a share on Thursday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in